05/10/2024 7:53 AM | Verona Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024 8:09 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 6:22 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:18 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/03/2024 6:19 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:21 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/03/2024 6:23 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/30/2024 3:15 PM | Brady James Aloysius (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:16 PM | Cunningham Kenneth (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:17 PM | SHAH MAHENDRA (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:17 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:17 PM | EBSWORTH DAVID R (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:17 PM | Ullman Anders (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:17 PM | Edwards Martin (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:18 PM | Sinha Vikas (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:15 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024 7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024 6:45 PM | Gupta Rishi (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024 8:40 PM | Fisher Andrew (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/04/2024 7:15 PM | ORBIMED ADVISORS LLC (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 8:00 AM | Verona Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 5:08 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 5:09 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:10 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:11 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 5:05 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/02/2024 5:07 AM | Austwick Michael (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 3:15 PM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 4:09 PM | Edwards Martin (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:15 PM | EBSWORTH DAVID R (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:08 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:09 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 7:11 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 3:25 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023 3:16 PM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Claim your free seat by clicking here now. |
11/02/2023 5:24 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 3:06 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 3:06 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 5:02 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2023 3:05 PM | ACKERMANN CHRISTINA (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:15 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:17 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 8:19 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:31 PM | Hahn Mark W (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:27 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:29 PM | Verona Pharma (Issuer) ZACCARDELLI DAVID (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 7:30 PM | Poll Claire (Reporting) Verona Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/03/2023 3:12 PM | Rickard Kathleen A. (Reporting) Verona Pharma (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023 7:34 AM | Verona Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023 5:11 AM | Verona Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |